Abstract
An antimicrobial is an agent capable of killing or inhibiting the growth of a micro-organism. Antimicrobial prophylaxis encompasses efforts to prevent postprocedure infections through the use of an antimicrobial agent before, and, in some cases, for a limited time after a procedure. A thorough history and physical examination are essential to identify host factors that increase a patient's risk for postprocedural infection. Risk-modifying factors include age, anatomy, geographical area of residence, immune and nutritional status, cardiac valve integrity, prosthetic joints, the presence of indwelling hardware and distant infectious wounds. Prophylaxis for the most common urologic outpatient procedures can be attained with oral trimethoprim–sulfamethoxazole or fluoroquinolone administered between 2 h and 30 min before a procedure. Special consideration for the type and duration of prophylaxis should be given to patients with moderate to severe cardiac valvular conditions and recently inserted prosthetic joints.
Key Points
-
There are several local and systemic factors that increase the chances of a patient developing a postprocedure infection, including poor nutritional status, advanced age and compromised immunity; such risk-modifying factors influence not only the chance a patient has of developing an infection, but how serious the consequences of that infection might be
-
A number of adverse effects are associated with antimicrobial medications, ranging from gastrointestinal disturbances to allergic reactions; it is, therefore, important to consider patient factors when selecting an appropriate antimicrobial agent
-
A full medical history and physical examination should be conducted before deciding if antimicrobial prophylaxis is appropriate in order to identify whether a patient has any risk-modifying factors
-
Routine antimicrobial prophylaxis is not indicated in patients undergoing catheterization, cystoscopy or urodynamic investigations, but can be useful in some patients with risk-modifying factors
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bratzler DW and Houck PM (2004) Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38: 1706–1715
Parsons CL et al. (1980) Antibacterial activity of bladder surface mucin duplicated in the rabbit bladder by exogenous glycosaminoglycan (sodium pentosanpolysulfate). Infect Immun 27: 876–881
Williams DH and Schaeffer AJ (2004) Current concepts in urinary tract infections. Minerva Urol Nefrol 56: 15–31
Schaeffer AJ (2002) New concepts in the pathogenesis of urinary tract infections. Urol Clin North Am 29: 241–250
Kehinde EO et al. (2004) Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J Endourol 18: 891–896
Mangram AJ et al. (1999) Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 27: 97–132
American Academy of Orthopaedic Surgeons and American Urological Association (online December 2002) Advisory Statement: antimicrobial prophylaxis for urological patients with total joint replacement [http://www.aaos.org/wordhtml/papers/advistmt/1023.htm] (accessed 7 September 2005)
Dajani AS et al. (1997) Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 277: 1794–1801
Centers for Disease Control and Prevention. Antibiotic/Antimicrobial Resistance [http://www.cdc.gov/drugresistance] (accessed 2 November 2005)
Turck M et al. (1962) The urethral catheter and urinary tract infection. J Urol 88: 834–837
Thiel G and Spuhler O (1965) Catheter infection and so–called infectious (episomal) resistance[German]. Schweiz Med Wochenschr 95: 1155–1157
Garibaldi RA et al. (1974) Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med 291: 215–219
Kass EH (1956) Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 64: 56–64
Liedl B (2001) Catheter-associated urinary tract infections. Curr Opin Urol 11: 75–79
Nickel JC et al. (1985) Catheter-associated bacteriuria. An experimental study. Urology 26: 369–375
Clarke SA et al. (2005) Are prophylactic antibiotics necessary with clean intermittent catheterization? A randomized controlled trial. J Pediatr Surg 40: 568–571
Duffy LM et al. (1995) Clean intermittent catheterization: safe, cost-effective bladder management for male residents of VA nursing homes. J Am Geriatr Soc 43: 865–870
Schlager TA et al. (1998) Nitrofurantoin prophylaxis for bacteriuria and urinary tract infection in children with neurogenic bladder on intermittent catheterization. J Pediatr 132: 704–708
Harding GK et al. (1991) How long should catheter-acquired urinary tract infection in women be treated? A randomized controlled study. Ann Intern Med 114: 713–719
Hustinx WN et al. (1991) Impact of concurrent antimicrobial therapy on catheter-associated urinary tract infection. J Hosp Infect 18: 45–56
Polastri F et al. (1990) Absence of significant bacteremia during urinary catheter manipulation in patients with chronic indwelling catheters. J Am Geriatr Soc 38: 1203–1208
Burke DM et al. (2002) The community-based morbidity of flexible cystoscopy. BJU Int 89: 347–349
Clark KR and Higgs MJ (1990) Urinary infection following out-patient flexible cystoscopy. Br J Urol 66: 503–505
Rane A et al. (2001) The issue of prophylactic antibiotics prior to flexible cystoscopy. Eur Urol 39: 212–214
Almallah YZ et al. (2000) Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation. Urology 56: 37–39
Manson AL (1988) Is antibiotic administration indicated after outpatient cystoscopy. J Urol 140: 316–317
Cundiff GW et al. (1999) Randomized trial of antibiotic prophylaxis for combined urodynamics and cystourethroscopy. Obstet Gynecol 93: 749–752
Peschers UM et al. (2001) Antibiotic treatment to prevent urinary tract infections after urodynamic evaluation. Int Urogynecol J Pelvic Floor Dysfunct 12: 254–257
Baker KR et al. (1991) Effectiveness of antibiotic prophylaxis in preventing bacteriuria after multichannel urodynamic investigations: a blind, randomized study in 124 female patients. Am J Obstet Gynecol 165: 679–681
Payne SR et al. (1988) Microbiological look at urodynamic studies. Lancet 2: 1123–1126
Raaijmakers R et al. (2002) Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 60: 826–830
Sieber PR et al. (1997) Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 157: 2199–2200
Carey JM and Korman HJ (2001) Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 166: 82–85
Griffith BC et al. (2002) Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 168: 1021–1023
Aron M et al. (2000) Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85: 682–685
Sabbagh R et al. (2004) A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy. Can J Urol 11: 2216–2219
Kapoor DA et al. (1998) Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52: 552–558
Isen K et al. (1999) Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim–sulfamethoxazole. Int Urol Nephrol 31: 491–495
Pearle MS and Roehrborn CG (1997) Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: a meta-analysis and cost-effectiveness analysis. Urology 49: 679–686
O'Keeffe NK et al. (1993) Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. Br J Urol 72: 277–283
Pearson NJ et al. (1979) Emergence of trimethoprim-resistant enterobacteria in patients receiving long-term co-trimoxazole for the control of intractable urinary-tract infection. Lancet 2: 1205–1208
Acknowledgements
Special thanks to AJ Schaeffer and ME Nielsen for critical reviews of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Schaeffer, E. Prophylactic use of antimicrobials in commonly performed outpatient urologic procedures. Nat Rev Urol 3, 24–31 (2006). https://doi.org/10.1038/ncpuro0357
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro0357
This article is cited by
-
Antibiotikaprophylaxe bei transurethraler Resektion der Prostata (TUR-P)
Der Urologe (2009)